Biosynex SA (ALBIO.PA)

EUR 1.4

(0.0%)

Net Debt Summary of Biosynex SA

Biosynex SA's latest annual net debt in 2023 was 45.43 Million EUR , up 229.42% from previous year.
Biosynex SA's latest quarterly net debt in 2023 FY was 45.43 Million EUR , up 229.42% from previous quarter.
Biosynex SA reported annual net debt of -35.1 Million EUR in 2022, up 63.71% from previous year.
Biosynex SA reported annual net debt of -96.72 Million EUR in 2021, down -359.13% from previous year.
Biosynex SA reported quarterly net debt of 24.71 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Biosynex SA reported quarterly net debt of 45.43 Million EUR for 2023 FY, up 229.42% from previous quarter.

Annual Net Debt Chart of Biosynex SA (2023 - 2009)

Historical Annual Net Debt of Biosynex SA (2023 - 2009)

Year	Net Debt	Net Debt Growth
2023	45.43 Million EUR	229.42%
2022	-35.1 Million EUR	63.71%
2021	-96.72 Million EUR	-359.13%
2020	-21.06 Million EUR	-359.5%
2019	8.11 Million EUR	143.59%
2018	3.33 Million EUR	-14.15%
2017	3.88 Million EUR	-38.31%
2016	6.29 Million EUR	108.62%
2015	3.01 Million EUR	401.27%
2014	601.7 Thousand EUR	-74.61%
2013	2.36 Million EUR	-5.19%
2012	2.49 Million EUR	1058.35%
2011	215.73 Thousand EUR	-36.28%
2010	338.57 Thousand EUR	-30.39%
2009	486.35 Thousand EUR	0.0%

Year	Net Debt	Net Debt Growth
2023 Q4	45.43 Million EUR	0.0%
2023 Q2	24.71 Million EUR	0.0%
2023 FY	45.43 Million EUR	229.42%
2022 Q4	-35.1 Million EUR	0.0%
2022 FY	-35.1 Million EUR	63.71%
2022 Q2	-57.06 Million EUR	0.0%
2021 Q4	-96.72 Million EUR	0.0%
2021 Q2	-74.68 Million EUR	0.0%
2021 FY	-96.72 Million EUR	-359.13%
2020 Q2	1.23 Million EUR	0.0%
2020 Q4	-21.06 Million EUR	0.0%
2020 FY	-21.06 Million EUR	-359.5%
2019 Q2	3.84 Million EUR	0.0%
2019 FY	8.11 Million EUR	143.59%
2019 Q4	8.11 Million EUR	0.0%
2018 Q4	3.33 Million EUR	0.0%
2018 FY	3.33 Million EUR	-14.15%
2018 Q2	5.01 Million EUR	0.0%
2017 FY	3.88 Million EUR	-38.31%
2017 Q2	8.27 Million EUR	0.0%
2017 Q4	4.41 Million EUR	0.0%
2016 FY	6.29 Million EUR	108.62%
2016 Q2	2.89 Million EUR	0.0%
2016 Q4	7.83 Million EUR	0.0%
2015 Q2	4.57 Million EUR	0.0%
2015 FY	3.01 Million EUR	401.27%
2015 Q4	3.29 Million EUR	0.0%
2014 Q4	601.7 Thousand EUR	0.0%
2014 FY	601.7 Thousand EUR	-74.61%
2014 Q2	1.07 Million EUR	0.0%
2013 Q2	2.27 Million EUR	0.0%
2013 FY	2.36 Million EUR	-5.19%
2013 Q4	2.36 Million EUR	0.0%
2012 Q4	2.49 Million EUR	0.0%
2012 Q2	2.63 Million EUR	0.0%
2012 FY	2.49 Million EUR	1058.35%
2011 FY	215.73 Thousand EUR	-36.28%
2011 Q4	215.73 Thousand EUR	0.0%
2011 Q2	363.56 Thousand EUR	0.0%
2010 FY	338.57 Thousand EUR	-30.39%
2010 Q4	338.57 Thousand EUR	0.0%
2009 FY	486.35 Thousand EUR	0.0%

Peer Net Debt Comparison of Biosynex SA

Name	Net Debt	Net Debt Difference
Predilife S.A.	4.67 Million EUR	-872.391%
bioMérieux S.A.	166.39 Million EUR	72.698%
Eurofins Scientific SE	4.17 Billion EUR	98.913%
Lumibird SA	88.88 Million EUR	48.887%